# Mangoceuticals, Inc.: Form 8-K, filed Apr 11, 2024

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: 8-K
- Filed: 2024-04-11
- Accepted by EDGAR: Apr 11, 2024, 16:30 ET
- Period: 2024-04-05
- Accession: 0001493152-24-014330
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224014330/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000149315224014330/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000149315224014330/form8-k.htm

Filed Apr 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-014330. Last ingested by Listed: Nov 15, 2026, 00:08 ET. No prices; not investment advice.
